FGP
CME icon

Foyston, Gordon, & Payne’s CME Group CME Stock Holding History

Foyston, Gordon, & Payne’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Sell
12,281
-2,169
-15% -$600K 0.58% 46
2026
Q1 		$4.27M Sell
14,450
-31
-0.2% -$9.21K 0.98% 37
2025
Q4 		$3.95M Sell
14,481
-326
-2% -$88.6K 0.86% 36
2025
Q3 		$4M Sell
14,807
-587
-4% -$160K 0.87% 36
2025
Q2 		$4.24M Buy
15,394
+158
+1% +$43K 0.97% 32
2025
Q1 		$4.04M Buy
15,236
+143
+0.9% +$35.3K 1% 32
2024
Q4 		$3.51M Buy
15,093
+15
+0.1% +$3.45K 0.93% 33
2024
Q3 		$3.33M Sell
15,078
-7,038
-32% -$1.46M 0.83% 37
2024
Q2 		$4.35M Sell
22,116
-300
-1% -$62K 1.07% 33
2024
Q1 		$4.83M Buy
22,416
+3,786
+20% +$795K 1.16% 35
2023
Q4 		$3.92M Buy
18,630
+462
+3% +$98.6K 0.99% 40
2023
Q3 		$3.64M Buy
18,168
+5,319
+41% +$1.06M 0.99% 38
2023
Q2 		$2.38M Sell
12,849
-358
-3% -$66.2K 0.62% 42
2023
Q1 		$2.53M Sell
13,207
-6,713
-34% -$1.21M 0.68% 43
2022
Q4 		$3.35M Sell
19,920
-5,575
-22% -$969K 0.93% 41
2022
Q3 		$4.52M Buy
25,495
+11,952
+88% +$2.36M 1.24% 30
2022
Q2 		$4.09M Sell
13,543
-6,740
-33% -$1.43M 1.18% 33
2022
Q1 		$4.83M Buy
20,283
+1,345
+7% +$316K 1.18% 31
2021
Q4 		$4.33M Sell
18,938
-279
-1% -$61.4K 1.01% 37
2021
Q3 		$3.72M Buy
19,217
+120
+0.6% +$24.3K 0.93% 36
2021
Q2 		$4.06M Sell
19,097
-2,080
-10% -$439K 0.97% 35
2021
Q1 		$4.33M Sell
21,177
-1,006
-5% -$198K 1.02% 34
2020
Q4 		$4.04M Sell
22,183
-1,534
-6% -$261K 0.97% 37
2020
Q3 		$3.97M Buy
+23,717
New +$3.99M 1.02% 33

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Foyston, Gordon, & Payne's CME Position: Q2 2026 in Review

Foyston, Gordon, & Payne reduced its CME Group (CME) stake by 15% in Q2 2026, selling an estimated $600K and leaving 12,281 shares worth $2.71M. The position accounts for 0.58% of the portfolio, ranked #46.

Foyston, Gordon, & Payne first reported a position in CME in Q3 2020 and has held it in 24 quarters since. The position peaked at $4.83M in Q1 2024. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Foyston, Gordon, & Payne held 12,281 shares of CME Group worth $2.71M as of Q2 2026.
  • Foyston, Gordon, & Payne sold 2,169 CME Group shares in Q2 2026, an estimated $600K.
  • CME Group made up 0.58% of Foyston, Gordon, & Payne's portfolio in Q2 2026, its #46 holding.
  • Foyston, Gordon, & Payne first reported a position in CME Group in Q3 2020 and has held it in 24 quarters since.
  • Foyston, Gordon, & Payne's CME Group position peaked at $4.83M in Q1 2024.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2026, filed 12 Aug 2026.